Target Details
| UniProt AC | P51617 |
|---|---|
| Gene Symbol | IRAK1 |
| Protein Name | Interleukin-1 receptor-associated kinase 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00531 (Death) PF00069 (Pkinase) |
Summary
- Multi-target molecules 312
- Clinical molecules 15
- Avg pChEMBL 6.84
KEGG Pathways (20)
- Alcoholic liver disease
- Chagas disease
- Coronavirus disease - COVID-19
- Epstein-Barr virus infection
- Hepatitis B
- Herpes simplex virus 1 infection
- Human immunodeficiency virus 1 infection
- Leishmaniasis
- Lipid and atherosclerosis
- MAPK signaling pathway
- Measles
- NF-kappa B signaling pathway
- Neurotrophin signaling pathway
- Pathogenic Escherichia coli infection
- Pertussis
- Salmonella infection
- Toll-like receptor signaling pathway
- Toxoplasmosis
- Tuberculosis
- Yersinia infection
Active Molecules (312)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
ZVVNQPGCNBMROC
|
6.3 | IC50 | 2 | — | |
ZXICHULZXNAPKS
|
6.3 | IC50 | 2 | — | |
ZZPZTQIZEUBASL
|
6.3 | IC50 | 2 | — | |
JFKRMJRQGVELFG
|
6.2 | IC50 | 3 | — | |
YEZSPJXJBLNYQO
|
6.2 | IC50 | 3 | — | |
BKDJJDIXKRUBLT
|
6.2 | IC50 | 2 | — | |
CLRGCYMGDBZQTB
|
6.2 | Ki | 2 | — | |
MUYFQIQEBJQOGI
|
6.2 | IC50 | 2 | — | |
OSVUGUHRKMMBSE
|
6.2 | Kd | 170 | — | |
UBPYILGKFZZVDX
|
6.2 | Kd | 130 | Yes | |
UAIANIHUMMKHJR
|
6.2 | IC50 | 3 | — | |
BPJQSSSZFGZEOF
|
6.2 | Ki | 4 | — | |
DFMCXVONDDGQIY
|
6.2 | Ki | 66 | — | |
HOBMVEVXDIOMDM
|
6.2 | Ki | 18 | — | |
PYXQMJSGJIJHJT
|
6.2 | Ki | 28 | — | |
RYAVJHIPOWNWDE
|
6.2 | Ki | 38 | — | |
UOVCGJXDGOGOCZ
|
6.2 | Ki | 59 | — | |
YPJJSXBVVGPFHA
|
6.2 | Ki | 18 | — | |
NQZRHTLUKLOASK
|
6.2 | IC50 | 3 | — | |
OWIYRPIJTDKPDU
|
6.2 | IC50 | 2 | — | |
ITDPQZHRPNERLI
|
6.2 | IC50 | 3 | — | |
BBKKFCZZAZLULJ
|
6.2 | IC50 | 2 | — | |
PHXJVRSECIGDHY
|
6.2 | Kd | 59 | — | |
RAIGSWRYTFZVQJ
|
6.2 | IC50 | 2 | — | |
DURNYYKOVXELMP
|
6.2 | IC50 | 3 | — | |
HRNAVIYNHGZRMP
|
6.1 | IC50 | 3 | — | |
LYUCMSBGXASQAS
|
6.1 | IC50 | 2 | — | |
FAYAUAZLLLJJGH
|
6.1 | Ki | 36 | Yes | |
GHAHLIVGSBTTLD
|
6.1 | IC50 | 2 | — | |
GUMBHNMWKMFKRT
|
6.1 | Ki | 23 | — | |
JANBIXNDYNRYQP
|
6.1 | IC50 | 2 | — | |
KWSZYBNXNYRQCC
|
6.1 | Ki | 21 | — | |
KYACBMRLQMEIAI
|
6.1 | Ki | 30 | — | |
NWAUBAGBGOPJLF
|
6.1 | Ki | 51 | Yes | |
OLUKILHGKRVDCT
|
6.1 | Ki | 44 | Yes | |
SQXSMLLCDWJNAC
|
6.1 | Ki | 20 | — | |
TUJUZVJICDSNLY
|
6.1 | Ki | 19 | — | |
XSDJOIOVIMPMHD
|
6.1 | Ki | 44 | — | |
XSRHBCYNCKAFKS
|
6.1 | Ki | 45 | — | |
FQVCSBNTPQDQSS
|
6.1 | IC50 | 3 | — | |
UIEHXCCYHAUOFD
|
6.1 | IC50 | 3 | — | |
VJDQIINVHIBHNW
|
6.1 | IC50 | 2 | — | |
IYZWULIJOWJSKT
|
6.1 | IC50 | 2 | — | |
FKNJKNHEBUMLTR
|
6.0 | IC50 | 2 | — | |
RGJUJSDOHVLJHD
|
6.0 | IC50 | 2 | — | |
DJVYXMINSBMUHH
|
6.0 | IC50 | 3 | — | |
PGPHHJBZEGSUNE
|
6.0 | Kd | 21 | — | |
PGPHHJBZEGSUNE
|
6.0 | Kd | 17 | — | |
PPIGWXNYCGUCMZ
|
6.0 | IC50 | 2 | — | |
BUJSZRICYLPWCM
|
6.0 | IC50 | 3 | — |